Hillcrest Signs First Commercial Licensing Deal With Equipmake for Heavy-Duty EV Inverter
HLRTF is trading near its 52-week low of $0.057 (6.0% above the low).
Summary
Hillcrest signed its first definitive commercial licensing agreement, a Technology Collaboration Agreement with UK drivetrain maker Equipmake (AQSE:EQIP) to jointly develop an 800-volt traction inverter using Hillcrest's ZVS technology for heavy-duty trucks, buses and off-highway equipment. If the inverter meets agreed acceptance criteria, Equipmake gets exclusive manufacturing and sales rights in those markets and pays Hillcrest a royalty on net sales. This follows the October 5 disclosure that the two had expanded talks to include commercial licensing terms, and the September 29 peer-reviewed results showing more than 90% reduction in motor-terminal voltage overshoot. The deal matters because it gives a pre-revenue, micro-cap clean-tech company a path to market through a partner that already builds and sells drivetrains, with no manufacturing spend of its own, while Hillcrest keeps all ZVS intellectual property. The catch: no royalty revenue until Equipmake starts commercial sales, the development program only starts after a technical spec and resource plan are finalized within six months, and either party can walk after the first prototype.
At the time of this announcement, HLRTF was trading at $0.06 on OTC in the Energy & Transportation sector, with a market capitalization of approximately $12.6M. The 52-week trading range was $0.06 to $0.17. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: ACCESS Newswire.